Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 12 studies | 29% ± 8% | |
| endothelial cell | 11 studies | 22% ± 6% | |
| glutamatergic neuron | 10 studies | 36% ± 25% | |
| oligodendrocyte | 10 studies | 36% ± 12% | |
| GABAergic neuron | 6 studies | 37% ± 21% | |
| oligodendrocyte precursor cell | 5 studies | 29% ± 10% | |
| neuron | 4 studies | 26% ± 10% | |
| epithelial cell | 4 studies | 31% ± 9% | |
| respiratory goblet cell | 4 studies | 21% ± 5% | |
| goblet cell | 4 studies | 36% ± 25% | |
| ionocyte | 3 studies | 28% ± 6% | |
| retinal ganglion cell | 3 studies | 43% ± 15% | |
| club cell | 3 studies | 19% ± 3% | |
| capillary endothelial cell | 3 studies | 20% ± 5% | |
| interneuron | 3 studies | 49% ± 23% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 35% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5064.10 | 1445 / 1445 | 99% | 53.52 | 182 / 183 |
| intestine | 100% | 3140.15 | 966 / 966 | 99% | 43.43 | 524 / 527 |
| prostate | 100% | 3227.90 | 245 / 245 | 99% | 43.29 | 498 / 502 |
| thymus | 100% | 3868.62 | 653 / 653 | 99% | 63.48 | 600 / 605 |
| stomach | 100% | 2502.69 | 359 / 359 | 99% | 40.15 | 283 / 286 |
| lung | 99% | 3392.52 | 575 / 578 | 99% | 43.48 | 1145 / 1155 |
| breast | 100% | 2973.91 | 459 / 459 | 98% | 48.58 | 1095 / 1118 |
| adrenal gland | 100% | 6996.12 | 258 / 258 | 97% | 68.54 | 223 / 230 |
| brain | 99% | 4556.43 | 2613 / 2642 | 98% | 37.05 | 688 / 705 |
| bladder | 100% | 2341.24 | 21 / 21 | 96% | 31.84 | 486 / 504 |
| uterus | 98% | 1771.31 | 167 / 170 | 90% | 30.43 | 411 / 459 |
| pancreas | 90% | 1145.61 | 294 / 328 | 98% | 38.22 | 174 / 178 |
| kidney | 99% | 1712.48 | 88 / 89 | 87% | 20.60 | 784 / 901 |
| skin | 83% | 3982.46 | 1497 / 1809 | 87% | 28.18 | 409 / 472 |
| ovary | 54% | 594.58 | 97 / 180 | 95% | 23.27 | 410 / 430 |
| spleen | 100% | 2243.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2367.54 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 39.45 | 44 / 45 |
| heart | 94% | 1432.39 | 806 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 18.78 | 27 / 29 |
| blood vessel | 93% | 1379.93 | 1237 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 35% | 880.84 | 325 / 929 | 0% | 0 | 0 / 0 |
| liver | 2% | 17.92 | 5 / 226 | 28% | 6.29 | 115 / 406 |
| muscle | 20% | 164.81 | 157 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 13% | 1.67 | 10 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042590 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class I |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MFSD6 |
| Protein name | Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog) Major facilitator superfamily domain containing 6 |
| Synonyms | MMR2 |
| Description | |
| Accessions | ENST00000445546.1 ENST00000432036.5 ENST00000444317.1 C9JJH2 ENST00000281416.11 C9IYL1 ENST00000417958.5 H7C0X2 H7C284 C9J134 Q6ZSS7 ENST00000412482.1 C9JAZ7 ENST00000392328.6 ENST00000434582.5 |